# National Influenza Genomic Surveillance Report  
**Country:**  
**Influenza Season:** (e.g., 2025 Southern Hemisphere)  
**Reporting Period:** (Start date – End date)  
**Prepared by:** National Influenza Center / Genomic Surveillance Unit  
**Date of Report:**  

---

## 1. Executive Summary

This report summarizes influenza virus genomic surveillance conducted during the **[season]** influenza season in **[country]**. Surveillance integrates routine virological testing with whole-genome sequencing to monitor circulating influenza strains, genetic diversity, antiviral resistance markers, and phylogenetic relationships.

Key findings:
- Total specimens tested: **[N]**
- Influenza-positive specimens: **[N]**
- Viruses sequenced: **[N]**
- Dominant clades/subclades: **[e.g., A(H1N1)pdm09 clade 6B.1A.5a]**
- Antiviral resistance marker H275Y detected in **[N]** viruses

---

## 2. Surveillance System and Sample Collection

### 2.1 Surveillance Design

Specimens were collected through:
- ☐ Sentinel outpatient influenza-like illness (ILI) surveillance  
- ☐ Severe acute respiratory infection (SARI) surveillance  
- ☐ Hospital-based surveillance  
- ☐ Outbreak investigations  
- ☐ Other: **[specify]**

### 2.2 Sample Collection Method

- **Specimen type:** (e.g., nasopharyngeal swab, oropharyngeal swab)
- **Collection medium:** (e.g., viral transport medium)
- **Testing laboratories:** **[list]**
- **Age groups included:** **[e.g., all ages / ≥6 months]**
- **Geographic coverage:** **[national / subnational regions]**

---

## 3. Virological Screening Results

### 3.1 Total Specimens Tested

| Metric | Count |
|------|------:|
| Total specimens tested | |
| Influenza-positive specimens | |
| Influenza-negative specimens | |

### 3.2 Influenza Type and Subtype Distribution

| Virus Type / Subtype | Count | Percentage (%) |
|---------------------|------:|---------------:|
| Influenza A (total) | | |
| └─ A(H1N1)pdm09 | | |
| └─ A(H3N2) | | |
| Influenza B (total) | | |
| └─ B/Victoria lineage | | |
| └─ B/Yamagata lineage | | |
| **Total influenza positive** | | 100 |

---

## 4. Sequencing Overview

### 4.1 Sequencing Selection Criteria

Specimens were selected for sequencing based on:
- ☐ Ct value ≤ **[threshold]**
- ☐ Geographic representation
- ☐ Temporal distribution across season
- ☐ Age group or clinical severity
- ☐ Other: **[specify]**

### 4.2 Sequencing Output and Quality

| Metric | Count |
|------|------:|
| Influenza-positive specimens eligible for sequencing | |
| Specimens submitted for sequencing | |
| Successfully sequenced genomes | |
| Genomes passing QC thresholds | |
| Genomes failing QC | |

**Passing rate:** **[X%]** (passing QC / sequenced)

QC thresholds included:
- Minimum genome coverage: **[e.g., ≥90%]**
- Maximum ambiguous bases (Ns): **[e.g., ≤5%]**

---

## 5. Clade and Subclade Distribution (Nextclade)

Clade assignment was performed using **Nextclade** (version **[X]**, dataset **[Y]**).

### 5.1 Influenza A(H1N1)pdm09

| Clade / Subclade | Count | Percentage (%) |
|------------------|------:|---------------:|
| | | |
| | | |
| **Total** | | 100 |

### 5.2 Influenza A(H3N2)

| Clade / Subclade | Count | Percentage (%) |
|------------------|------:|---------------:|
| | | |
| | | |
| **Total** | | 100 |

### 5.3 Influenza B

| Lineage / Clade | Count | Percentage (%) |
|-----------------|------:|---------------:|
| | | |
| | | |
| **Total** | | 100 |

---

## 6. Antiviral Resistance Markers

### 6.1 Neuraminidase H275Y (A(H1N1)pdm09)

| Metric | Count |
|------|------:|
| A(H1N1)pdm09 genomes analyzed | |
| Viruses with H275Y mutation | |
| Percentage with H275Y | |

**Interpretation:**  
The H275Y substitution is associated with reduced susceptibility to oseltamivir.

---

## 7. Phylogenetic Analysis

### 7.1 Methods

- **Alignment:** **[e.g., MAFFT]**
- **Phylogenetic inference:** **[e.g., IQ-TREE / FastTree]**
- **Reference strains:** WHO vaccine reference strains for the **[season]** season
- **Gene(s) analyzed:** ☐ HA ☐ NA ☐ Whole genome

### 7.2 Phylogenetic Tree Summary

- Circulating viruses clustered primarily with **[reference clade/strain]**
- No major divergent clusters were observed ☐ / Divergent clusters were observed ☐
- Genetic diversity was **[low / moderate / high]**

### 7.3 Phylogenetic Tree

*(Insert tree image or link here)*


---

## 8. Data Sharing

- Sequences submitted to: ☐ GISAID ☐ GenBank
- Number of sequences shared: **[N]**
- Accession IDs: **[range or link]**

---

## 9. Limitations

- Sequencing coverage may not be fully representative of all regions.
- Selection bias due to Ct-based sequencing thresholds.
- Turnaround time varied during peak transmission periods.

---

## 10. Conclusions and Public Health Implications

Genomic surveillance during the **[season]** influenza season demonstrated **[key findings]**, supporting national and global influenza risk assessment and vaccine strain selection processes.

---

## 11. Acknowledgements

We acknowledge sentinel sites, laboratories, clinicians, and data contributors supporting influenza surveillance in **[country]**.

---

## 12. Contact Information

**Institution:**  
**Email:**  
**Phone:**  

 
